Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load. - Wikidata - wikimedia - TriplyDB

Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load.

Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load.

http://www.wikidata.org/entity/Q37436136

about

Targeting the Brain Reservoirs: Toward an HIV Cure Neurocognitive impairment in patients treated with protease inhibitor monotherapy or triple drug antiretroviral therapy HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment.Clinical Trials in Neurovirology: Successes, Challenges, and Pitfalls Relationship of Human Immunodeficiency Virus Viral Load in Cerebrospinal Fluid and Plasma in Patients Co-infected With Cryptococcal Meningitis.Diffuse White Matter Signal Abnormalities on Magnetic Resonance Imaging Are Associated With Human Immunodeficiency Virus Type 1 Viral Escape in the Central Nervous System Among Patients With Neurological Symptoms Temporal Patterns and Drug Resistance in CSF Viral Escape Among ART-Experienced HIV-1 Infected Adults The cerebrospinal fluid HIV risk score for assessing central nervous system activity in persons with HIV.HIV-associated neurocognitive disorder.Evolving character of chronic central nervous system HIV infection.Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection.Controversies in HIV-associated neurocognitive disorders Effect of protein binding on unbound atazanavir and darunavir cerebrospinal fluid concentrations.The cerebrospinal fluid biomarker profile in an HIV-infected subject with Alzheimer's disease.Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study.Deep sequencing of HIV-1 variants from paired plasma and cerebrospinal fluid during primary HIV infection Better Antiretroviral Central Nervous System Penetration is Not Associated with Reduced Chronic Pain in People Living with Human Immunodeficiency Virus.Monocyte/macrophages and their role in HIV neuropathogenesis.Tissue reservoirs of HIV Cerebrospinal fluid HIV-1 compartmentalization in a patient with AIDS and acute varicella-zoster virus meningomyeloradiculitis.Cerebrospinal fluid analysis for HIV replication and biomarkers of immune activation and neurodegeneration in long-term atazanavir/ritonavir monotherapy treated patients.CSF viral escape in a patient with HIV-associated neurocognitive disorder.HIV-associated neurocognitive disorders: recent advances in pathogenesis, biomarkers, and treatment.HIV and neurocognitive dysfunction.Approach to cerebrospinal fluid (CSF) biomarker discovery and evaluation in HIV infection.Neurological Complications in Controlled HIV Infection.Neurologic disease in HIV-infected children and the impact of combination antiretroviral therapy.Update on HIV dementia and HIV-associated neurocognitive disorders.HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment.Pharmacokinetics and pharmacodynamics of antiretrovirals in the central nervous system.Neuropathogenesis of HIV: from initial neuroinvasion to HIV-associated neurocognitive disorder (HAND)Cerebrospinal Fluid HIV Escape from Antiretroviral Therapy.Viral Escape in the Central Nervous System with Multidrug-Resistant Human Immunodeficiency Virus-1.HIV-associated Neurocognitive Disorders and Antiretroviral Therapy: Current Concepts and Controversies.CNS reservoirs for HIV: implications for eradication.Immune activation in the central nervous system throughout the course of HIV infection.Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls.Fate of microglia during HIV-1 infection: From activation to senescence?Neurologic Complications in Treated HIV-1 Infection.Cognitive Impairment and Persistent CNS Injury in Treated HIV.

P2860

Q28075694-5FC15684-8658-4135-B318-C6556F02C7C9 Q28534903-8E013E89-6ED9-4D40-995B-085C8B634775 Q30234305-C60C826A-56AE-46C3-BC87-2F6FECEAFBF2 Q30250271-DF9BD986-339B-46E8-976F-7F2076275647 Q33609454-4193D64C-AF08-4E52-98C9-95D737E55FD8 Q33712027-BB12204C-C0FB-47E1-86BB-3B9612BF0470 Q33750994-08934981-1F42-4BFE-B4C1-A0DF90C082BE Q33938797-C8EC1D02-6069-4990-8366-A192CCC89DFA Q33939729-F2798C1B-4B18-4A60-B5EA-1EA1FAA132A2 Q33995713-16DDAC8F-F0CB-4D52-8EDC-381E0C48F82A Q34776835-31460E6C-7C11-491E-997A-E271BBEEF29C Q35037015-0ED394D2-DB21-43E5-BA3B-0F3C186ED604 Q35404442-FA4903A3-80C2-4BAC-B115-890FB064B094 Q35848870-ED32D9DC-E4AD-4AB4-B620-39F01CDA1C43 Q36538745-A7FCFA93-BFE0-412B-B2F6-FFC97A0FD61C Q36551179-E9C26B60-009A-4CBD-81B7-1DE868036A96 Q36798111-2AC7804D-6044-4668-AF1D-F3DD24A0CABE Q36991666-623923D0-DEA6-4120-B190-905728F7338B Q37055454-979FDF23-9014-4009-8EE3-3E39CAA6B58A Q37084988-0FBB4B2D-54B6-4D84-9B84-F41BF65B5960 Q37116803-3BAD22B9-9EC3-4714-AC4B-DE82E835E541 Q37138383-516FFD28-464C-48C0-A2BB-279449A2F911 Q37720509-30003243-C2A1-4D2C-9C4A-E75CD3ED8243 Q38122104-D5A118EB-0651-4058-9D3F-2FCD50FF401D Q38128778-3AC14BF3-1AEC-4B7B-9B57-DD71FDAC56D1 Q38154239-3E3CB5E7-516D-418D-93CC-B8D64CB5878D Q38210096-CB835CF0-C0E9-47F3-B0B7-3DEFF9E04B60 Q38220991-E42A76FB-7B53-4F90-9575-45D38C360537 Q38223328-801B3F9E-FDAE-43CF-B5ED-A5988BA6119B Q38247035-B3CA6CEE-E973-456E-B0E7-9F33EA1648C5 Q38258410-09B218FC-83D7-4525-A2D3-7A3336ECD958 Q38414364-B7418DE3-A799-4AB8-B245-3F9E9BF7684B Q38426959-3D73232E-3322-43FB-98AC-98422A856A0C Q38444808-945542D4-04FE-449A-8690-8804C34C7B2C Q38597765-90012DF4-1E11-4465-A3F9-32F72D72BFEC Q38694693-0B7A7E24-AD65-470D-BCC4-B87C9C2F0818 Q38734471-30008BB3-B2C0-4DFB-AA07-31759630945C Q38790617-6844DB1F-EF82-4F46-8A7C-0555D8190B60 Q38832560-4FD089A1-F779-4F9B-8129-08E41DEEC159 Q38836472-C9717768-A731-4B1D-B21F-4FDD5F3330D8

P2860

Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load.

http://www.wikidata.org/entity/Q37436136

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cerebrospinal fluid HIV escape ...... controlled plasma viral load.

@en

Cerebrospinal fluid HIV escape ...... controlled plasma viral load.

@nl

type

label

Cerebrospinal fluid HIV escape ...... controlled plasma viral load.

@en

Cerebrospinal fluid HIV escape ...... controlled plasma viral load.

@nl

prefLabel

Cerebrospinal fluid HIV escape ...... controlled plasma viral load.

@en

Cerebrospinal fluid HIV escape ...... controlled plasma viral load.

@nl

P1433

Q37436136-A9FF57FA-143A-44FA-B07E-D4C4D3B3B740

P1476

Q37436136-6F959D65-DF97-4275-848D-D0164964C86C

P2093

Q37436136-02735856-8AF4-4E00-AE98-E56CB6D3F13D

Q37436136-081DE1DB-54DE-4E77-96C5-5CCB74ED1F72

Q37436136-0C71305A-C11D-4883-8641-5FA80333AEAE

Q37436136-1C92ACA4-DA81-4B2D-80AA-98B676416006

Q37436136-644E2756-F5EF-4D90-9C4C-0C6D4DF3A9E5

Q37436136-667F29EC-08C0-4FD6-A8A3-EAA374FF003B

Q37436136-74F040AA-F313-4F81-A5D6-980EC0AA8363

Q37436136-BE591B5E-7C66-4A84-B4ED-D7920671CC8E

Q37436136-C478A45A-0E02-4BAC-A8DA-60AFB2A2CEB3

Q37436136-EBDB6D73-B33B-4DC7-97D8-7157EEBE85F3

P2860

Q37436136-1147F364-DDCC-4150-AB7B-B10A10240CAA

Q37436136-1BB8A677-AA90-4530-9799-A91E47CC08A7

Q37436136-316E1245-6A2F-45FD-A982-C33C836678D1

Q37436136-3AE2D9A8-3F78-4E4C-8A9E-E95A67C10E57

Q37436136-3B5D3759-D5D0-43C6-8C27-49D7E140234A

Q37436136-64D927FB-AC62-44D1-9976-0CDC38E129A9

Q37436136-65D92C3B-3D3B-4D11-9C0E-0A0FE12EC5E4

Q37436136-6B84B3B0-187F-473D-9729-83458863509B

Q37436136-6E51A6B3-3CCC-4F1A-B605-358EBEAFD0F0

Q37436136-8744C2AC-FAC2-45DB-9532-916F61929334

P304

Q37436136-6A4A734D-1898-4FB7-9C1F-8B0DD736E4BB

P31

Q37436136-98E2C83F-F072-418B-8FE8-7B3C35B97A36

P356

Q37436136-6BC1FA4A-1803-4466-A376-51F1E1C4773D

P407

Q37436136-3D23609F-C054-43D5-9914-55541A250A8C

P433

Q37436136-9DCC6658-C508-4828-8D17-B0DD00AEE9CB

P478

Q37436136-4579D627-9D42-43DF-830B-80BA4020813A

P577

Q37436136-B35658EB-797E-4777-A494-9719DD4684E1

P698

Q37436136-FE214568-2E61-4F5B-9812-A79B975ADDE1

P921

Q37436136-3743740A-93BC-49E6-BC35-4B4389702265

Q37436136-70D732E5-1094-4A59-A7F5-7E3F5B1411A5

Q37436136-92767B96-A427-429D-B673-B0AAE656442C

Q37436136-C63BEFFC-1632-40C7-9EE5-292486F5B5D1

Q37436136-F792BCFE-FBE4-44E6-A2C5-8CAD7E7DC584

P932

Q37436136-72453947-396F-4C29-BCA8-D753DFAC765A

P356

QAD.0B013E328355E6B2

P1433

P1476

Cerebrospinal fluid HIV escape ...... controlled plasma viral load.

@en

P2093

Antonio Boschini

http://www.w3.org/2001/XMLSchema#string

Dietmar Fuchs

http://www.w3.org/2001/XMLSchema#string

Evelyn Lee

http://www.w3.org/2001/XMLSchema#string

Francesca Ferretti

http://www.w3.org/2001/XMLSchema#string

Julia Peterson

http://www.w3.org/2001/XMLSchema#string

Magnus Gisslén

http://www.w3.org/2001/XMLSchema#string

Michael J Peluso

http://www.w3.org/2001/XMLSchema#string

Nancy Angoff

http://www.w3.org/2001/XMLSchema#string

Paola Cinque

http://www.w3.org/2001/XMLSchema#string

Richard W Price

http://www.w3.org/2001/XMLSchema#string

P2860

Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment

Increased human immunodeficiency virus type 1 (HIV-1) env compartmentalization in the presence of HIV-1-associated dementia

Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection.

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort.

Neopterin as a marker for immune system activation.

HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment

Updated research nosology for HIV-associated neurocognitive disorders

Neopterin in HIV-1 infection.

Antiretroviral therapy and central nervous system HIV type 1 infection

P304

1765-1774

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAD.0B013E328355E6B2

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22614889

http://www.w3.org/2001/XMLSchema#string

P921

cerebrospinal fluid

antiretroviral drug

P932

3881435

http://www.w3.org/2001/XMLSchema#string